TNXP Earnings Tonix Pharmaceuticals Holding Corp.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -2.93 | 2026-05-11 | 10-Q |
| FY 2025 | 2025-12-31 | -14.57 | 2026-03-12 | 10-K |
| Q3 2025 | 2025-09-30 | -10.42 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | -6.80 | 2025-08-11 | 10-Q |
| Q1 2026 | 2025-03-31 | -2.84 | 2026-05-11 | 10-Q |
| FY 2025 | 2024-12-31 | -176.60 | 2026-03-12 | 10-K |
| Q3 2025 | 2024-09-30 | -466.17 | 2025-11-10 | 10-Q |
| Q2 2025 | 2024-06-30 | -2720.40 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -535.72 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -14720.25 | 2025-03-18 | 10-K |
| Q3 2024 | 2023-09-30 | -143.47 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -107.45 | 2024-08-16 | 10-Q |
| Q1 2024 | 2023-03-31 | -3.21 | 2024-05-13 | 10-Q |
| FY 2023 | 2022-12-31 | -20.01 | 2024-04-01 | 10-K |
| Q3 2023 | 2022-09-30 | -18.58 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -17.28 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.61 | 2023-05-08 | 10-Q |
| FY 2022 | 2021-12-31 | -8.10 | 2023-03-13 | 10-K |
| Q3 2022 | 2021-09-30 | -6.02 | 2022-11-07 | 10-Q |
| Q2 2022 | 2021-06-30 | -4.49 | 2022-08-08 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.